[1] Gatselis N K, Zachou K, Koukoulis G K, et al. Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol, 2015, 21(1): 60-83.
[2] Casal Moura M, Liberal R, Cardoso H, et al. Management of autoimmune hepatitis: Focus on pharmacologic treatments beyond corticosteroids. World J Hepatol, 2014, 6(6): 410-418.
[3] Turnbaugh P J, Ley R E, Mahowald M A, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 2006, 444(7122): 1027-1031.
[4] Rowland I, Gibson G, Helnken A, et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutrit, 2018, 57(1): 1-24.
[5] Jia X, Xu W, Zhang L, et al. Impact of gut microbiota and microbiota-related metabolites on hyperlipidemia. Front Cell Infect Microbiol, 2021, 11: 634780.
[6] Rosser E C, Piper C J M, Matei D E, et al. Microbiota-derived metabolites suppress arthritis by amplifying aryl-hydrocarbon receptor activation in regulatory B cells. Cell Metab, 2020, 31(4): 837-851, e10.
[7] Borrey Y E, Moloney R D, Clarke G, et al. The impact of microbiota on brain and behavior: Mechanisms & therapeutic potential. oxyg Transp Tiss, 2014, 817: 373-403.
[8] Appleton J. The gut-brain axis: Influence of microbiota on mood and mental health. Integrat Med (Encinitas, Calif), 2018, 17(4): 28-32.
[9] Cheng Z, Yang L, Chu H. The gut microbiota: A novel player in autoimmune hepatitis. Front Cell Infect Microbiol, 2022, 12: 947382.
[10] Kumen M, Holm K, Anmarkrud J A, et al. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls. Gut, 2017, 66(4): 611-6119.
[11] Wang R, Tang R, Li B, et al. Gut microbiome, liver immunology, and liver diseases. Cell Mol Immunol, 2021, 18(1): 4-17.
[12] Nguyen H D, Aliamaei H M, Stadnyk A W. The production and function of endogenous interleukin-10 in intestinal epithelial cells and gut homeostasis. Cell Mol Gastroenterol Hepatol, 12(4): 1343-1352.
[13] Belkaid Y, Hand T W. Role of the microbiota in immunity and inflammation. Cell, 2014, 157(1): 121-141.
[14] Takiishi T, Fenero C I M, C Mara N O S. Intestinal barrier and gut microbiota: Shaping our immune responses throughout life. Tiss Barri, 2017, 5(4): e1373208.
[15] Zhang Y J, Li S, Gan R Y, et al. Impacts of gut bacteria on human health and diseases. Int J Mol Sci, 2015, 16(4): 7493.
[16] Konturek P C, Harsch I A, Konturek K K, et al. Gut-liver axis: How do gut bacteria influence the liver? Medil Sci (Basel, Switzerland), 2018, 6(3):231-136
[17] Luo M, Xin R J, Hu F R, et al. Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy via the gut-liver-brain axis World J Gastroenterol, 2023, 29(1): 144-156.
[18] Liang M, Zhu LW, Shen JG, et al. Fecal microbiota transplantation controls progression of experimental autoimmune hepatitis in mice by modulating the TFR/TFH immune imbalance and intestinal microbiota composition. Front Immunol, 2021, 12: 728723.
[19] Towle T R, Kulkarni C A, Oppegard L M, et al. Design, synthesis, and evaluation of novel N-1 fluoroquinolone derivatives: Probing for binding contact with the active site tyrosine of gyrase. Bioorgan Med Chemist Lett, 2018, 28(10):324.
[20] Wang X, Zhang P, Zhang X. Probiotics regulate gut microbiota: An effective method to improve immunity. Molecules, 2021, 26(19):2121-2127. |
